A detailed history of Spirepoint Private Client, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Spirepoint Private Client, LLC holds 50,478 shares of PFE stock, worth $1.4 Million. This represents 0.2% of its overall portfolio holdings.

Number of Shares
50,478
Previous 51,286 1.58%
Holding current value
$1.4 Million
Previous $1.42 Billion 0.76%
% of portfolio
0.2%
Previous 0.22%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024

SELL
$25.26 - $29.6 $20,410 - $23,916
-808 Reduced 1.58%
50,478 $1.41 Billion
Q1 2024

May 10, 2024

BUY
$25.89 - $29.73 $1.33 Million - $1.52 Million
51,286 New
51,286 $1.42 Billion

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $156B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Spirepoint Private Client, LLC Portfolio

Follow Spirepoint Private Client, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Spirepoint Private Client, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Spirepoint Private Client, LLC with notifications on news.